Heparanase procoagulant effects and inhibition by heparins (Q44606727)

4 December 2017

title

Heparanase procoagulant effects and inhibition by heparins (English)

1 reference

4 December 2017

2

Benjamin Brenner

1 reference

4 December 2017

Yona Nadir

1

1 reference

4 December 2017

language of work or name

1 reference

1 April 2010

1 reference

4 December 2017

1 reference

4 December 2017

volume

125 Suppl 2

1 reference

4 December 2017

page(s)

S72-6

1 reference

The prothrombotic state in cancer: pathogenic mechanisms

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Acquired activated protein C resistance is common in cancer patients and is associated with venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Tissue factor-factor VIIa signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Emerging insights in tissue factor-dependent signaling events.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Regulation of functions of vascular wall cells by tissue factor pathway inhibitor: basic and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Tissue factor pathway inhibitor: structure, biology and involvement in disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Human platelet heparanase: purification, characterization and catalytic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Substrate specificity of heparanases from human hepatoma and platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Heparanase, a potential regulator of cell-matrix interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Cloning and functional expression of a human heparanase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Human heparanase. Purification, characterization, cloning, and expression

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Expression pattern and secretion of human and chicken heparanase are determined by their signal peptide sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Heparanase expression in human colorectal cancer and its relationship to tumor angiogenesis, hematogenous metastasis, and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Human heparanase-1 gene expression in pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Heparanase protein and gene expression in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Expression of three extracellular matrix degradative enzymes in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Heparanase expression is an independent prognostic factor in patients with invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Heparanase-1 expression is associated with the metastatic potential of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Heparanase: a key enzyme in invasion and metastasis of gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Heparanase expression at the invasion front of human head and neck cancers and correlation with poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Heparanase expression in human leukemias is restricted to acute myeloid leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Human heparanase nuclear localization and enzymatic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Localization of heparanase in esophageal cancer cells: respective roles in prognosis and differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Heparanase localization and expression by head and neck cancer: correlation with tumor progression and patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Characterization of HPSE gene single nucleotide polymorphisms in Jewish populations of Israel

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Association of heparanase gene (HPSE) single nucleotide polymorphisms with hematological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Lack of association of the heparanase gene single-nucleotide polymorphism Arg307Lys with acute lymphoblastic leukaemia in patients from Northern Ireland

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Heparanase gene haplotype (CGC) is associated with stage of disease in patients with ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Localization of anticoagulantly active heparan sulfate proteoglycans in vascular endothelium: antithrombin binding on cultured endothelial cells and perfused rat aorta

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Synthesis of Anticoagulantly Active Heparan Sulfate Proteoglycans by Glomerular Epithelial Cells Involves Multiple 3-O-Sulfotransferase Isoforms and a Limiting Precursor Pool

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Cell surface heparan sulfate proteoglycans participate in factor VIII catabolism mediated by low density lipoprotein receptor-related protein

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Role of heparan sulfate proteoglycans in the uptake and degradation of tissue factor pathway inhibitor-coagulation factor Xa complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Basement membrane proteoglycans: from cellar to ceiling

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Evidence that sulphated polysaccharides inhibit tumour metastasis by blocking tumour-cell-derived heparanases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Heparanase induces tissue factor expression in vascular endothelial and cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Heparanase induces endothelial cell migration via protein kinase B/Akt activation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Increased tissue factor pathway inhibitor in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Circadian variation in plasma levels of free-form tissue factor pathway inhibitor antigen in patients with coronary spastic angina

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Changes in plasma tissue factor pathway inhibitor levels during the clinical course of disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Tissue factor pathway inhibitor in childhood nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Elevated TFPI in malignant disease: relation to cancer type and hypercoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Elevated plasma levels of the factor Xa-TFPI complex in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

An ELISA method for the detection and quantification of human heparanase

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

The impact of heparanese and heparin on cancer metastasis and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Heparanase expression in nasopharyngeal carcinoma inversely correlates with patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Signaling of the tissue factor coagulation pathway in angiogenesis and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Procoagulant and Anticoagulant Mechanisms in Human Placenta

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Estradiol induces heparanase-1 expression and heparan sulphate proteoglycan degradation in human endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

Heparanase Expression Correlates with Invasion and Poor Prognosis in Gastric Cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970018-9

7 January 2021

10.1016/S0049-3848(10)70018-9

Identifiers

DOI

1 reference

4 December 2017

1 reference